Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 306

1.

Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers.

Knaup H, Stahl K, Schmidt BMW, Idowu TO, Busch M, Wiesner O, Welte T, Haller H, Kielstein JT, Hoeper MM, David S.

Crit Care. 2018 Oct 30;22(1):285. doi: 10.1186/s13054-018-2220-9.

2.

Cologne consensus conference on pulmonary hypertension - Update 2018.

Rosenkranz S, Ghofrani HA, Grünig E, Klose H, Olschewski H, Hoeper MM.

Int J Cardiol. 2018 Sep 22. pii: S0167-5273(18)35665-1. doi: 10.1016/j.ijcard.2018.09.064. [Epub ahead of print] No abstract available.

PMID:
30344062
3.

Risk assessment in patients with systemic sclerosis and pulmonary arterial hypertension.

Olsson KM, Hoeper MM.

Eur Respir J. 2018 Oct 18;52(4). pii: 1801745. doi: 10.1183/13993003.01745-2018. Print 2018 Oct. No abstract available.

PMID:
30337490
4.

Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients.

Delcroix M, Staehler G, Gall H, Grünig E, Held M, Halank M, Klose H, Vonk-Noordegraaf A, Rosenkranz S, Pepke-Zaba J, Opitz CF, Gibbs JSR, Lange TJ, Tsangaris I, Huscher D, Pittrow D, Olsson KM, Hoeper MM.

Eur Respir J. 2018 Nov 8;52(5). pii: 1800248. doi: 10.1183/13993003.00248-2018. Print 2018 Nov.

PMID:
30337446
5.

Cardio-pulmonary MRI for detection of treatment response after a single BPA treatment session in CTEPH patients.

Schoenfeld C, Hinrichs JB, Olsson KM, Kuettner MA, Renne J, Kaireit T, Czerner C, Wacker F, Hoeper MM, Meyer BC, Vogel-Claussen J.

Eur Radiol. 2018 Oct 11. doi: 10.1007/s00330-018-5696-4. [Epub ahead of print]

PMID:
30311032
6.

Long-term safety and outcome of intravenous treprostinil via an implanted pump in pulmonary hypertension.

Richter MJ, Harutyunova S, Bollmann T, Classen S, Gall H, Gerhardt Md F, Grimminger F, Grimminger J, Grünig E, Guth S, Halank M, Heine A, Hoeper MM, Klose H, Lange TJ, Meyer K, Neurohr C, Nickolaus K, Olsson KM, Opitz CF, Rosenkranz S, Seyfarth HJ, Warnke C, Wiedenroth C, Ghofrani HA, Ewert R.

J Heart Lung Transplant. 2018 Oct;37(10):1235-1244. doi: 10.1016/j.healun.2018.06.006. Epub 2018 Jun 21.

PMID:
30293617
7.

Risk stratification strategy and assessment of disease progression in patients with pulmonary arterial hypertension: Updated Recommendations from the Cologne Consensus Conference 2018.

Leuchte HH, Ten Freyhaus H, Gall H, Halank M, Hoeper MM, Kaemmerer H, Kähler C, Riemekasten G, Ulrich S, Schwaiblmair M, Ewert R.

Int J Cardiol. 2018 Sep 13. pii: S0167-5273(18)34351-1. doi: 10.1016/j.ijcard.2018.08.084. [Epub ahead of print]

PMID:
30266353
8.

C-Arm computed tomography (CACT)-guided balloon pulmonary angioplasty (BPA): Evaluation of patient safety and peri- and post-procedural complications.

Maschke SK, Hinrichs JB, Renne J, Werncke T, Winther HMB, Ringe KI, Olsson KM, Hoeper MM, Wacker FK, Meyer BC.

Eur Radiol. 2018 Sep 12. doi: 10.1007/s00330-018-5694-6. [Epub ahead of print]

PMID:
30209593
9.

Risk-stratified outcomes with initial combination therapy in pulmonary arterial hypertension: Application of the REVEAL risk score.

Frost AE, Hoeper MM, Barberá JA, Vachiery JL, Blair C, Langley J, Rubin LJ.

J Heart Lung Transplant. 2018 Sep 9. pii: S1053-2498(18)31540-7. doi: 10.1016/j.healun.2018.07.001. [Epub ahead of print]

PMID:
30209017
10.

Chronic thromboembolic pulmonary hypertension (CTEPH): Updated Recommendations from the Cologne Consensus Conference 2018.

Wilkens H, Konstantinides S, Lang IM, Bunck AC, Gerges M, Gerhardt F, Grgic A, Grohé C, Guth S, Held M, Hinrichs JB, Hoeper MM, Klepetko W, Kramm T, Krüger U, Lankeit M, Meyer BC, Olsson KM, Schäfers HJ, Schmidt M, Seyfarth HJ, Ulrich S, Wiedenroth CB, Mayer E.

Int J Cardiol. 2018 Aug 28. pii: S0167-5273(18)34354-7. doi: 10.1016/j.ijcard.2018.08.079. [Epub ahead of print]

PMID:
30195840
11.

Targeted therapy of pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018.

Hoeper MM, Apitz C, Grünig E, Halank M, Ewert R, Kaemmerer H, Kabitz HJ, Kähler C, Klose H, Leuchte H, Ulrich S, Olsson KM, Distler O, Rosenkranz S, Ghofrani HA.

Int J Cardiol. 2018 Aug 25. pii: S0167-5273(18)34349-3. doi: 10.1016/j.ijcard.2018.08.082. [Epub ahead of print]

PMID:
30190158
12.

Decompensated right heart failure, intensive care and perioperative management in patients with pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018.

Olsson KM, Halank M, Egenlauf B, Fistera D, Gall H, Kaehler C, Kortmann K, Kramm T, Lichtblau M, Marra AM, Nagel C, Sablotzki A, Seyfarth HJ, Schranz D, Ulrich S, Hoeper MM, Lange TJ.

Int J Cardiol. 2018 Aug 26. pii: S0167-5273(18)34348-1. doi: 10.1016/j.ijcard.2018.08.081. [Epub ahead of print]

PMID:
30190155
13.

Improved short- and long-term outcome of allogeneic stem cell recipients admitted to the intensive care unit: a retrospective longitudinal analysis of 942 patients.

Lueck C, Stadler M, Koenecke C, Hoeper MM, Dammann E, Schneider A, Kielstein JT, Ganser A, Eder M, Beutel G.

Intensive Care Med. 2018 Sep;44(9):1483-1492. doi: 10.1007/s00134-018-5347-x. Epub 2018 Aug 23.

PMID:
30141173
14.

Pulmonary hypertension due to lung diseases: Updated recommendations from the Cologne Consensus Conference 2018.

Olschewski H, Behr J, Bremer H, Claussen M, Douschan P, Halank M, Held M, Hoeper MM, Holt S, Klose H, Krüger S, Lange TJ, Reichenberger F, Skowasch D, Ulrich S, Wilkens H, Seeger W.

Int J Cardiol. 2018 Aug 11. pii: S0167-5273(18)34353-5. doi: 10.1016/j.ijcard.2018.08.043. [Epub ahead of print]

PMID:
30131231
15.

MRI-derived Regional Biventricular Function in Patients with Chronic Thromboembolic Pulmonary Hypertension Before and After Pulmonary Endarterectomy.

Maschke SK, Schoenfeld CO, Kaireit TF, Cebotari S, Olsson K, Hoeper M, Wacker F, Vogel-Claussen J.

Acad Radiol. 2018 May 2. pii: S1076-6332(18)30184-3. doi: 10.1016/j.acra.2018.04.002. [Epub ahead of print]

PMID:
29730148
16.

Age, risk and outcomes in idiopathic pulmonary arterial hypertension.

Hoeper MM, Boucly A, Sitbon O.

Eur Respir J. 2018 May 3;51(5). pii: 1800629. doi: 10.1183/13993003.00629-2018. Print 2018 May. No abstract available.

PMID:
29724788
17.

Quantitation of Perfused Lung Volume Using Hybrid SPECT/CT Allows Refining the Assessment of Lung Perfusion and Estimating Disease Extent in Chronic Thromboembolic Pulmonary Hypertension.

Derlin T, Kelting C, Hueper K, Weiberg D, Meyer K, Olsson KM, Thackeray JT, Welte T, Bengel FM, Hoeper MM.

Clin Nucl Med. 2018 Jun;43(6):e170-e177. doi: 10.1097/RLU.0000000000002085.

PMID:
29688945
18.

Chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: to screen or not to screen?

Hoeper MM.

Eur Respir J. 2018 Apr 4;51(4). pii: 1800440. doi: 10.1183/13993003.00440-2018. Print 2018 Apr. No abstract available.

PMID:
29618607
19.

Risk assessment in pulmonary arterial hypertension.

Hoeper MM, Pittrow D, Opitz C, Gibbs JSR, Rosenkranz S, Grünig E, Olsson KM, Huscher D.

Eur Respir J. 2018 Mar 29;51(3). pii: 1702606. doi: 10.1183/13993003.02606-2017. Print 2018 Mar. No abstract available.

PMID:
29599117
20.

REVEAL risk score in patients with chronic thromboembolic pulmonary hypertension receiving riociguat.

Benza RL, Farber HW, Frost A, Grünig E, Hoeper MM, Busse D, Meier C, Nikkho S, Ghofrani HA.

J Heart Lung Transplant. 2018 Jul;37(7):836-843. doi: 10.1016/j.healun.2018.02.015. Epub 2018 Mar 1.

21.

Incidence and characteristics of chronic thromboembolic pulmonary hypertension in Germany.

Kramm T, Wilkens H, Fuge J, Schäfers HJ, Guth S, Wiedenroth CB, Weingard B, Huscher D, Pittrow D, Cebotari S, Hoeper MM, Mayer E, Olsson KM.

Clin Res Cardiol. 2018 Jul;107(7):548-553. doi: 10.1007/s00392-018-1215-5. Epub 2018 Feb 15.

22.

Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality.

McLaughlin VV, Hoeper MM, Channick RN, Chin KM, Delcroix M, Gaine S, Ghofrani HA, Jansa P, Lang IM, Mehta S, Pulido T, Sastry BKS, Simonneau G, Sitbon O, Souza R, Torbicki A, Tapson VF, Perchenet L, Preiss R, Verweij P, Rubin LJ, Galiè N.

J Am Coll Cardiol. 2018 Feb 20;71(7):752-763. doi: 10.1016/j.jacc.2017.12.010.

23.

The 6MWT as a prognostic tool in pulmonary arterial hypertension: results from the COMPERA registry.

Zelniker TA, Huscher D, Vonk-Noordegraaf A, Ewert R, Lange TJ, Klose H, Dumitrescu D, Halank M, Held M, Gall H, Pittrow D, Hoeper MM, Frankenstein L.

Clin Res Cardiol. 2018 Jun;107(6):460-470. doi: 10.1007/s00392-018-1207-5. Epub 2018 Jan 24.

PMID:
29368137
24.

Targeting the Prostacyclin Pathway with Selexipag in Patients with Pulmonary Arterial Hypertension Receiving Double Combination Therapy: Insights from the Randomized Controlled GRIPHON Study.

Coghlan JG, Channick R, Chin K, Di Scala L, Galiè N, Ghofrani HA, Hoeper MM, Lang IM, McLaughlin V, Preiss R, Rubin LJ, Simonneau G, Sitbon O, Tapson VF, Gaine S.

Am J Cardiovasc Drugs. 2018 Feb;18(1):37-47. doi: 10.1007/s40256-017-0262-z.

25.

Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study.

McLaughlin VV, Jansa P, Nielsen-Kudsk JE, Halank M, Simonneau G, Grünig E, Ulrich S, Rosenkranz S, Gómez Sánchez MA, Pulido T, Pepke-Zaba J, Barberá JA, Hoeper MM, Vachiéry JL, Lang I, Carvalho F, Meier C, Mueller K, Nikkho S, D'Armini AM.

BMC Pulm Med. 2017 Dec 28;17(1):216. doi: 10.1186/s12890-017-0563-7.

26.

Advanced pulmonary arterial hypertension: mechanical support and lung transplantation.

Bartolome S, Hoeper MM, Klepetko W.

Eur Respir Rev. 2017 Dec 20;26(146). pii: 170089. doi: 10.1183/16000617.0089-2017. Print 2017 Dec 31. Review.

27.

REVEAL risk scores applied to riociguat-treated patients in PATENT-2: Impact of changes in risk score on survival.

Benza RL, Farber HW, Frost A, Ghofrani HA, Gómez-Sánchez MA, Langleben D, Rosenkranz S, Busse D, Meier C, Nikkho S, Hoeper MM.

J Heart Lung Transplant. 2018 Apr;37(4):513-519. doi: 10.1016/j.healun.2017.11.006. Epub 2017 Nov 11.

28.

Temporary treatment interruptions with oral selexipag in pulmonary arterial hypertension: Insights from the Prostacyclin (PGI2) Receptor Agonist in Pulmonary Arterial Hypertension (GRIPHON) study.

Preston IR, Channick RN, Chin K, Di Scala L, Farber HW, Gaine S, Galiè N, Ghofrani HA, Hoeper MM, Lang IM, McLaughlin VV, Preiss R, Simonneau G, Sitbon O, Tapson VF, Rubin LJ.

J Heart Lung Transplant. 2018 Mar;37(3):401-408. doi: 10.1016/j.healun.2017.09.024. Epub 2017 Oct 2.

PMID:
29096938
29.

Pulmonary vascular indices and survival in left heart disease: illusion of conclusion?

Rosenkranz S, Hoeper MM.

Eur J Heart Fail. 2018 Feb;20(2):256-259. doi: 10.1002/ejhf.1022. Epub 2017 Oct 19. No abstract available.

PMID:
29052305
30.

Plexiform Vasculopathy in Chronic Thromboembolic Pulmonary Hypertension.

Ackermann M, Gaumann A, Mentzer SJ, Hinrichs JB, Warnecke G, Hoeper MM, Braubach P, Kuehnel M, Maegel L, Jonigk D.

Am J Respir Crit Care Med. 2017 Oct 15;196(8):e48-e51. doi: 10.1164/rccm.201703-0591IM. No abstract available.

PMID:
28892403
31.

RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors.

Hoeper MM, Simonneau G, Corris PA, Ghofrani HA, Klinger JR, Langleben D, Naeije R, Jansa P, Rosenkranz S, Scelsi L, Grünig E, Vizza CD, Chang M, Colorado P, Meier C, Busse D, Benza RL.

Eur Respir J. 2017 Sep 9;50(3). pii: 1602425. doi: 10.1183/13993003.02425-2016. Print 2017 Sep.

32.

Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension.

Gaine S, Chin K, Coghlan G, Channick R, Di Scala L, Galiè N, Ghofrani HA, Lang IM, McLaughlin V, Preiss R, Rubin LJ, Simonneau G, Sitbon O, Tapson VF, Hoeper MM.

Eur Respir J. 2017 Aug 17;50(2). pii: 1602493. doi: 10.1183/13993003.02493-2016. Print 2017 Aug.

33.

Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.

Hoeper MM, Kramer T, Pan Z, Eichstaedt CA, Spiesshoefer J, Benjamin N, Olsson KM, Meyer K, Vizza CD, Vonk-Noordegraaf A, Distler O, Opitz C, Gibbs JSR, Delcroix M, Ghofrani HA, Huscher D, Pittrow D, Rosenkranz S, Grünig E.

Eur Respir J. 2017 Aug 3;50(2). pii: 1700740. doi: 10.1183/13993003.00740-2017. Print 2017 Aug.

PMID:
28775047
34.

More on idiopathic pulmonary arterial hypertension with a low diffusing capacity.

Olsson KM, Fuge J, Meyer K, Welte T, Hoeper MM.

Eur Respir J. 2017 Aug 3;50(2). pii: 1700354. doi: 10.1183/13993003.00354-2017. Print 2017 Aug. No abstract available.

PMID:
28775046
35.

Is there a vanishing pulmonary capillary syndrome?

Hoeper MM, Vonk-Noordegraaf A.

Lancet Respir Med. 2017 Sep;5(9):676-678. doi: 10.1016/S2213-2600(17)30291-6. Epub 2017 Jul 19. No abstract available.

PMID:
28734824
36.

Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a phase II long-term extension study.

Halank M, Hoeper MM, Ghofrani HA, Meyer FJ, Stähler G, Behr J, Ewert R, Fletcher M, Colorado P, Nikkho S, Grimminger F.

Respir Med. 2017 Jul;128:50-56. doi: 10.1016/j.rmed.2017.05.008. Epub 2017 May 16.

37.

Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: the initial German experience.

Olsson KM, Wiedenroth CB, Kamp JC, Breithecker A, Fuge J, Krombach GA, Haas M, Hamm C, Kramm T, Guth S, Ghofrani HA, Hinrichs JB, Cebotari S, Meyer K, Hoeper MM, Mayer E, Liebetrau C, Meyer BC.

Eur Respir J. 2017 Jun 8;49(6). pii: 1602409. doi: 10.1183/13993003.02409-2016. Print 2017 Jun.

PMID:
28596435
38.

Predicting recurrent pulmonary embolism and chronic thromboembolic pulmonary hypertension: one more way to skin the cat.

Klok FA, Hoeper MM.

Eur Respir J. 2017 May 25;49(5). pii: 1700413. doi: 10.1183/13993003.00413-2017. Print 2017 May. No abstract available.

PMID:
28546262
39.

Pulmonary Arterial Sarcoma Presenting as Acute Pulmonary Embolism.

David S, Hoeper MM, Vogel-Claussen J, Cebotari S.

Am J Respir Crit Care Med. 2017 Aug 15;196(4):523. doi: 10.1164/rccm.201703-0596IM. No abstract available.

PMID:
28504896
40.

Chronic thromboembolic pulmonary hypertension: Evaluation of 2D-perfusion angiography in patients who undergo balloon pulmonary angioplasty.

Maschke SK, Renne J, Werncke T, Olsson KM, Hoeper MM, Wacker FK, Meyer BC, Hinrichs JB.

Eur Radiol. 2017 Oct;27(10):4264-4270. doi: 10.1007/s00330-017-4806-z. Epub 2017 Mar 30.

PMID:
28361177
41.

An epidemiological analysis of the burden of chronic thromboembolic pulmonary hypertension in the USA, Europe and Japan.

Gall H, Hoeper MM, Richter MJ, Cacheris W, Hinzmann B, Mayer E.

Eur Respir Rev. 2017 Mar 29;26(143). pii: 160121. doi: 10.1183/16000617.0121-2016. Print 2017 Mar 31. Review.

42.

Medical management of chronic thromboembolic pulmonary hypertension.

Pepke-Zaba J, Ghofrani HA, Hoeper MM.

Eur Respir Rev. 2017 Mar 29;26(143). pii: 160107. doi: 10.1183/16000617.0107-2016. Print 2017 Mar 31. Review.

43.

The answer is blowing in the wind: an uncommon cause for severe ARDS accompanied by circulatory insufficiency requiring extracorporeal membrane oxygenation.

Einecke G, Beutel G, Hoeper MM, Kielstein JT.

BMJ Case Rep. 2017 Mar 24;2017. pii: bcr2016218079. doi: 10.1136/bcr-2016-218079.

PMID:
28343152
44.

Mid-term results of bilateral lung transplant with postoperatively extended intraoperative extracorporeal membrane oxygenation for severe pulmonary hypertension.

Salman J, Ius F, Sommer W, Siemeni T, Kuehn C, Avsar M, Boethig D, Molitoris U, Bara C, Gottlieb J, Welte T, Haverich A, Hoeper MM, Warnecke G, Tudorache I.

Eur J Cardiothorac Surg. 2017 Jul 1;52(1):163-170. doi: 10.1093/ejcts/ezx047.

PMID:
28329232
45.

Pulmonary Hypertension.

Hoeper MM, Ghofrani HA, Grünig E, Klose H, Olschewski H, Rosenkranz S.

Dtsch Arztebl Int. 2017 Feb 3;114(5):73-84. doi: 10.3238/arztebl.2017.0073. Review.

46.

Evaluation of the incidence of rare diseases: difficulties and uncertainties, the example of chronic thromboembolic pulmonary hypertension.

Simonneau G, Hoeper MM.

Eur Respir J. 2017 Feb 23;49(2). pii: 1602522. doi: 10.1183/13993003.02522-2016. Print 2017 Feb. No abstract available.

47.

Comparison of hemodynamic parameters in treatment-naïve and pre-treated patients with pulmonary arterial hypertension in the randomized phase III PATENT-1 study.

Galiè N, Grimminger F, Grünig E, Hoeper MM, Humbert M, Jing ZC, Keogh AM, Langleben D, Rubin LJ, Fritsch A, Davie N, Ghofrani HA.

J Heart Lung Transplant. 2017 May;36(5):509-519. doi: 10.1016/j.healun.2016.12.012. Epub 2016 Dec 24.

48.

First identification of Krüppel-like factor 2 mutation in heritable pulmonary arterial hypertension.

Eichstaedt CA, Song J, Viales RR, Pan Z, Benjamin N, Fischer C, Hoeper MM, Ulrich S, Hinderhofer K, Grünig E.

Clin Sci (Lond). 2017 Apr 25;131(8):689-698. doi: 10.1042/CS20160930. Epub 2017 Feb 10.

PMID:
28188237
49.

Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial.

Coghlan JG, Galiè N, Barberà JA, Frost AE, Ghofrani HA, Hoeper MM, Kuwana M, McLaughlin VV, Peacock AJ, Simonneau G, Vachiéry JL, Blair C, Gillies H, Miller KL, Harris JHN, Langley J, Rubin LJ; AMBITION investigators.

Ann Rheum Dis. 2017 Jul;76(7):1219-1227. doi: 10.1136/annrheumdis-2016-210236. Epub 2016 Dec 30.

50.

Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension.

Kim NH, D'Armini AM, Grimminger F, Grünig E, Hoeper MM, Jansa P, Mayer E, Neurohr C, Simonneau G, Torbicki A, Wang C, Fritsch A, Davie N, Ghofrani HA.

Heart. 2017 Apr;103(8):599-606. doi: 10.1136/heartjnl-2016-309621. Epub 2016 Dec 23.

Supplemental Content

Loading ...
Support Center